|
Volumn 299, Issue 5613, 2003, Pages 1694-1697
|
Dispelling the myths - Biocatalysis in industrial synthesis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOCHEMISTRY;
CATALYSIS;
DRUG PRODUCTS;
FOOD PRODUCTS;
MICROORGANISMS;
SYNTHESIS (CHEMICAL);
ENZYMATIC CONVERSIONS;
ENZYMES;
1,5 DIMETHYL 2 PIPERIDONE;
ACRYLAMIDE;
AMOXICILLIN;
ASPARTAME;
CEFALEXIN;
EPHEDRINE;
LEUCINE;
NICOTINAMIDE;
PIPERIDONE DERIVATIVE;
UNCLASSIFIED DRUG;
BIOCHEMISTRY;
CATALYSIS;
INDUSTRY;
AGRICULTURE;
BIOCATALYSIS;
BIODIVERSITY;
CATALYSIS;
CHEMICAL ANALYSIS;
DRUG BIOAVAILABILITY;
DRUG INDUSTRY;
DRUG SYNTHESIS;
ENZYME BINDING;
FOOD COMPOSITION;
GENOMICS;
METABOLIC ENGINEERING;
MOLECULAR EVOLUTION;
MOLECULAR STABILITY;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
BIOTECHNOLOGY;
CARBON;
CATALYSIS;
CHEMICAL INDUSTRY;
CHEMISTRY, ORGANIC;
COMPUTATIONAL BIOLOGY;
DIRECTED MOLECULAR EVOLUTION;
ECOSYSTEM;
ENZYME STABILITY;
ENZYMES;
GENETIC ENGINEERING;
KINETICS;
OXIDATION-REDUCTION;
PROTEIN ENGINEERING;
RECOMBINANT PROTEINS;
SUBSTRATE SPECIFICITY;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 0037436563
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1079237 Document Type: Review |
Times cited : (730)
|
References (43)
|